{"transactions":[{"id":1313491,"issuer":{"id":6780,"kind":"organization","name":"CareCloud, Inc.","symbol":"CCLD"},"owners":[{"id":84479,"kind":"person","name":"Steenvoorden Lawrence J.","position":1,"cik":"0001902795","reported_name":"Steenvoorden Lawrence J.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"No longer an employee"}}],"security":"Restricted Stock Unit","published_at":"2025-01-04T02:30:07.000Z","date":"2024-01-17","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":61549,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement and upon vesting, one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement and upon vesting, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 17, 2024, the restricted stock unit was cancelled by mutual agreement of the reporting person and the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 17, 2024, the restricted stock unit was cancelled by mutual agreement of the reporting person and the issuer."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":61549},"source":{"system":"sec-edgar","filing":"0001493152-25-000341","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582982/000149315225000341/ownership.xml","form_type":"5"}},{"id":1809553,"issuer":{"id":6780,"kind":"organization","name":"CareCloud, Inc.","symbol":"CCLD"},"owners":[{"id":84479,"kind":"person","name":"Steenvoorden Lawrence J.","position":1,"cik":"0001902795","reported_name":"Steenvoorden Lawrence J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-08-12T01:30:07.000Z","date":"2023-08-10","kind":"exercise","planned":false,"acquired":false,"shares":17097,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the conversion upon vesting of restricted stock units into common stock on August 10, 2023. These restricted stock units and the shares of common stock issued upon vesting of such units were acquired under the Company's Amended and Restated Equity Incentive Plan, without payment by the reporting person. The remaining restricted stock units vest between July 2024 and July 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the conversion upon vesting of restricted stock units into common stock on August 10, 2023. These restricted stock units and the shares of common stock issued upon vesting of such units were acquired under the Company's Amended and Restated Equity Incentive Plan, without payment by the reporting person. The remaining restricted stock units vest between July 2024 and July 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the conversion upon vesting of restricted stock units into common stock on August 10, 2023. These restricted stock units and the shares of common stock issued upon vesting of such units were acquired under the Company's Amended and Restated Equity Incentive Plan, without payment by the reporting person. The remaining restricted stock units vest between July 2024 and July 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the conversion upon vesting of restricted stock units into common stock on August 10, 2023. These restricted stock units and the shares of common stock issued upon vesting of such units were acquired under the Company's Amended and Restated Equity Incentive Plan, without payment by the reporting person. The remaining restricted stock units vest between July 2024 and July 2026."}],"balance_after":61549,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":17097},"source":{"system":"sec-edgar","filing":"0001493152-23-027927","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1582982/000149315223027927/ownership.xml","form_type":"4"}},{"id":1809552,"issuer":{"id":6780,"kind":"organization","name":"CareCloud, Inc.","symbol":"CCLD"},"owners":[{"id":84479,"kind":"person","name":"Steenvoorden Lawrence J.","position":1,"cik":"0001902795","reported_name":"Steenvoorden Lawrence J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-12T01:30:07.000Z","date":"2023-08-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":5984,"price":2.17,"value":12985.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld by the issuer to satisfy the mandatory tax withholding requirement upon awarding of the common stock. This is not an open market sale of securities."}],"balance_after":11113,"source":{"system":"sec-edgar","filing":"0001493152-23-027927","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1582982/000149315223027927/ownership.xml","form_type":"4"}},{"id":1809551,"issuer":{"id":6780,"kind":"organization","name":"CareCloud, Inc.","symbol":"CCLD"},"owners":[{"id":84479,"kind":"person","name":"Steenvoorden Lawrence J.","position":1,"cik":"0001902795","reported_name":"Steenvoorden Lawrence J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-12T01:30:07.000Z","date":"2023-08-10","kind":"exercise","planned":false,"acquired":true,"shares":17097,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the conversion upon vesting of restricted stock units into common stock on August 10, 2023. These restricted stock units and the shares of common stock issued upon vesting of such units were acquired under the Company's Amended and Restated Equity Incentive Plan, without payment by the reporting person. The remaining restricted stock units vest between July 2024 and July 2026."}],"balance_after":17097,"source":{"system":"sec-edgar","filing":"0001493152-23-027927","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582982/000149315223027927/ownership.xml","form_type":"4"}},{"id":1910508,"issuer":{"id":114014,"kind":"organization","name":"CHEMBIO DIAGNOSTICS, INC.","symbol":"CEMI"},"owners":[{"id":84479,"kind":"person","name":"Steenvoorden Lawrence J.","position":1,"cik":"0001902795","reported_name":"Steenvoorden Lawrence J.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Nonqualified stock options","published_at":"2023-05-01T21:03:34.000Z","date":"2023-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":300000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"As of the Effective Time, by virtue of the Merger and without any further action on the part of the holders thereof, Parent, Purchaser or the Issuer, each option which had a per share exercise price that is equal to or more than the Offer Price (each, an \"Out of the Money Option\") that was then outstanding and unexercised as of immediately before the Effective Time was cancelled at the Effective Time without any consideration payable therefor."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"As of the Effective Time, by virtue of the Merger and without any further action on the part of the holders thereof, Parent, Purchaser or the Issuer, each option which had a per share exercise price that is equal to or more than the Offer Price (each, an \"Out of the Money Option\") that was then outstanding and unexercised as of immediately before the Effective Time was cancelled at the Effective Time without any consideration payable therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"As of the Effective Time, by virtue of the Merger and without any further action on the part of the holders thereof, Parent, Purchaser or the Issuer, each option which had a per share exercise price that is equal to or more than the Offer Price (each, an \"Out of the Money Option\") that was then outstanding and unexercised as of immediately before the Effective Time was cancelled at the Effective Time without any consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":1.12,"expiration_date":"2029-01-05","underlying":"Common stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001140361-23-022238","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1092662/000114036123022238/form4.xml","form_type":"4"}},{"id":1910507,"issuer":{"id":114014,"kind":"organization","name":"CHEMBIO DIAGNOSTICS, INC.","symbol":"CEMI"},"owners":[{"id":84479,"kind":"person","name":"Steenvoorden Lawrence J.","position":1,"cik":"0001902795","reported_name":"Steenvoorden Lawrence J.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Restricted stock units","published_at":"2023-05-01T21:03:34.000Z","date":"2023-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":107143,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects disposition of Issuer common stock in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated January 31, 2023 (the \"Merger Agreement\"), by and among the Issuer, Biosynex SA (\"Parent\"), and Project Merci Merger Sub, Inc. (\"Purchaser\"), including the completion on April 26, 2023 of a tender offer to purchase all of the outstanding shares of Issuer common stock at a price of $0.45 per share in cash, without interest (the \"Offer Price\"), and the consummation of the merger (the \"Merger\") between the Issuer and Purchaser on April 27, 2023. Pursuant to the Merger Agreement, as of the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled in exchange for the right to receive an amount equal to the Offer Price."},{"field":"kind","element":"transactionCoding","label":"F5","text":"Each Company RSU (as defined in the Merger Agreement) that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive an amount in cash equal to the product of (a) the total number of Shares (as defined the Merger Agreement) issuable in settlement of such Company RSU immediately prior to the Effective Time without regard to vesting multiplied by (b) the Merger Consideration (as defined in the Merger Agreement)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each Company RSU (as defined in the Merger Agreement) that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive an amount in cash equal to the product of (a) the total number of Shares (as defined the Merger Agreement) issuable in settlement of such Company RSU immediately prior to the Effective Time without regard to vesting multiplied by (b) the Merger Consideration (as defined in the Merger Agreement)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each Company RSU (as defined in the Merger Agreement) that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive an amount in cash equal to the product of (a) the total number of Shares (as defined the Merger Agreement) issuable in settlement of such Company RSU immediately prior to the Effective Time without regard to vesting multiplied by (b) the Merger Consideration (as defined in the Merger Agreement)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each Company RSU (as defined in the Merger Agreement) that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive an amount in cash equal to the product of (a) the total number of Shares (as defined the Merger Agreement) issuable in settlement of such Company RSU immediately prior to the Effective Time without regard to vesting multiplied by (b) the Merger Consideration (as defined in the Merger Agreement)."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":107143},"source":{"system":"sec-edgar","filing":"0001140361-23-022238","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1092662/000114036123022238/form4.xml","form_type":"4"}},{"id":1910506,"issuer":{"id":114014,"kind":"organization","name":"CHEMBIO DIAGNOSTICS, INC.","symbol":"CEMI"},"owners":[{"id":84479,"kind":"person","name":"Steenvoorden Lawrence J.","position":1,"cik":"0001902795","reported_name":"Steenvoorden Lawrence J.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Restricted stock units","published_at":"2023-05-01T21:03:34.000Z","date":"2023-01-05","kind":"exercise","planned":false,"acquired":false,"shares":53571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 5, 2022, the reporting person was granted 160,714 restricted stock units which vest in three equal installments on January 5, 2023, 2024 and 2025, provided they shall vest in full immediately prior to (a) the issuer's termination of the reporting person employment without Cause, the reporting person's termination of his employment for Good Reason or the expiration of the Term upon notice of nonrenewal delivered by the Company, in each case within twelve months following a Change in Control, or (b) the reporting person's death or Permanent Disability (each such capitalized term as defined in the employment agreement between the issuer and the reporting person)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 5, 2022, the reporting person was granted 160,714 restricted stock units which vest in three equal installments on January 5, 2023, 2024 and 2025, provided they shall vest in full immediately prior to (a) the issuer's termination of the reporting person employment without Cause, the reporting person's termination of his employment for Good Reason or the expiration of the Term upon notice of nonrenewal delivered by the Company, in each case within twelve months following a Change in Control, or (b) the reporting person's death or Permanent Disability (each such capitalized term as defined in the employment agreement between the issuer and the reporting person)."}],"balance_after":107143,"derivative":{"underlying":"Common stock","underlying_shares":53571},"source":{"system":"sec-edgar","filing":"0001140361-23-022238","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1092662/000114036123022238/form4.xml","form_type":"4"}},{"id":1910505,"issuer":{"id":114014,"kind":"organization","name":"CHEMBIO DIAGNOSTICS, INC.","symbol":"CEMI"},"owners":[{"id":84479,"kind":"person","name":"Steenvoorden Lawrence J.","position":1,"cik":"0001902795","reported_name":"Steenvoorden Lawrence J.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2023-05-01T21:03:34.000Z","date":"2023-04-26","kind":"other","planned":false,"acquired":false,"shares":37453,"price":0.45,"value":16853.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects disposition of Issuer common stock in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated January 31, 2023 (the \"Merger Agreement\"), by and among the Issuer, Biosynex SA (\"Parent\"), and Project Merci Merger Sub, Inc. (\"Purchaser\"), including the completion on April 26, 2023 of a tender offer to purchase all of the outstanding shares of Issuer common stock at a price of $0.45 per share in cash, without interest (the \"Offer Price\"), and the consummation of the merger (the \"Merger\") between the Issuer and Purchaser on April 27, 2023. Pursuant to the Merger Agreement, as of the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled in exchange for the right to receive an amount equal to the Offer Price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects disposition of Issuer common stock in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated January 31, 2023 (the \"Merger Agreement\"), by and among the Issuer, Biosynex SA (\"Parent\"), and Project Merci Merger Sub, Inc. (\"Purchaser\"), including the completion on April 26, 2023 of a tender offer to purchase all of the outstanding shares of Issuer common stock at a price of $0.45 per share in cash, without interest (the \"Offer Price\"), and the consummation of the merger (the \"Merger\") between the Issuer and Purchaser on April 27, 2023. Pursuant to the Merger Agreement, as of the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled in exchange for the right to receive an amount equal to the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-23-022238","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1092662/000114036123022238/form4.xml","form_type":"4"}},{"id":1910504,"issuer":{"id":114014,"kind":"organization","name":"CHEMBIO DIAGNOSTICS, INC.","symbol":"CEMI"},"owners":[{"id":84479,"kind":"person","name":"Steenvoorden Lawrence J.","position":1,"cik":"0001902795","reported_name":"Steenvoorden Lawrence J.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2023-05-01T21:03:34.000Z","date":"2023-01-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":16118,"price":0.25,"value":4029.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were withheld for tax purposes upon the vesting of restricted stock units."}],"balance_after":37453,"source":{"system":"sec-edgar","filing":"0001140361-23-022238","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1092662/000114036123022238/form4.xml","form_type":"4"}},{"id":1910503,"issuer":{"id":114014,"kind":"organization","name":"CHEMBIO DIAGNOSTICS, INC.","symbol":"CEMI"},"owners":[{"id":84479,"kind":"person","name":"Steenvoorden Lawrence J.","position":1,"cik":"0001902795","reported_name":"Steenvoorden Lawrence J.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2023-05-01T21:03:34.000Z","date":"2023-01-05","kind":"exercise","planned":false,"acquired":true,"shares":53571,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":53571,"source":{"system":"sec-edgar","filing":"0001140361-23-022238","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1092662/000114036123022238/form4.xml","form_type":"4"}},{"id":2441992,"issuer":{"id":114014,"kind":"organization","name":"CHEMBIO DIAGNOSTICS, INC.","symbol":"CEMI"},"owners":[{"id":84479,"kind":"person","name":"Steenvoorden Lawrence J.","position":1,"cik":"0001902795","reported_name":"Steenvoorden Lawrence J.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Nonqualified stock options","published_at":"2022-01-06T21:00:36.000Z","date":"2022-01-05","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The nonqualified stock options are scheduled to vest in four equal installments on January 5, 2023, 2024, 2025 and 2026, provided they shall vest in full immediately prior to (a) the issuer's termination of the reporting person's employment without Cause, the reporting person's termination of his employment for Good Reason or the expiration of the Term upon notice of nonrenewal delivered by the Company, in each case within twelve months following a Change in Control, or (b) the reporting person's death or Permanent Disability (each such capitalized term as defined in the employment agreement between the issuer and the reporting person)."}],"balance_after":300000,"derivative":{"exercise_price":1.12,"expiration_date":"2029-01-05","underlying":"Common stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001140361-22-000875","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1092662/000114036122000875/form4.xml","form_type":"4"}},{"id":2441991,"issuer":{"id":114014,"kind":"organization","name":"CHEMBIO DIAGNOSTICS, INC.","symbol":"CEMI"},"owners":[{"id":84479,"kind":"person","name":"Steenvoorden Lawrence J.","position":1,"cik":"0001902795","reported_name":"Steenvoorden Lawrence J.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Restricted stock units","published_at":"2022-01-06T21:00:36.000Z","date":"2022-01-05","kind":"grant","acquired":true,"shares":160714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Common Stock"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units are scheduled to vest in three equal installments on January 5, 2023, 2024 and 2025, provided they shall vest in full immediately prior to (a) the issuer's termination of the reporting person employment without Cause, the reporting person's termination of his employment for Good Reason or the expiration of the Term upon notice of nonrenewal delivered by the Company, in each case within twelve months following a Change in Control, or (b) the reporting person's death or Permanent Disability (each such capitalized term as defined in the employment agreement between the issuer and the reporting person)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units are scheduled to vest in three equal installments on January 5, 2023, 2024 and 2025, provided they shall vest in full immediately prior to (a) the issuer's termination of the reporting person employment without Cause, the reporting person's termination of his employment for Good Reason or the expiration of the Term upon notice of nonrenewal delivered by the Company, in each case within twelve months following a Change in Control, or (b) the reporting person's death or Permanent Disability (each such capitalized term as defined in the employment agreement between the issuer and the reporting person)."}],"balance_after":160714,"derivative":{"underlying":"Common stock","underlying_shares":160714},"source":{"system":"sec-edgar","filing":"0001140361-22-000875","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1092662/000114036122000875/form4.xml","form_type":"4"}}]}